Physiologically based mechanistic insight into differential risk of valproate hepatotoxicity between children and adults: A focus on ontogeny impact
Abstract The anticonvulsant valproic acid (VPA) despite complex pharmacokinetics has been in clinical use for nearly 6 decades. Previous reports indicated neonates, infants, and toddlers/preschoolers had higher risk of valproate hepatotoxicity than adults. However, dosing recommendations for those l...
Saved in:
Main Authors: | Yu‐Ting Huang (Author), Yen‐Ming Huang (Author), Fan‐Lu Kung (Author), Chun‐Jung Lin (Author), Tun Jao (Author), Yunn‐Fang Ho (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Valproate-Associated Hepatotoxicity Update
by: J Gordon Millichap
Published: (1994) -
Valproate Hepatotoxicity in Children with Epilepsy
by: J Gordon Millichap
Published: (1987) -
Valproate-Induced Fatal Hepatotoxicity
by: J Gordon Millichap
Published: (1993) -
Valproate (VPA)-Associated Hepatotoxicity
by: J Gordon Millichap
Published: (1993) -
Reversible Valproate Hepatotoxicity and Associated Mitochondrial Disease
by: J Gordon Millichap
Published: (2008)